ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $550,000 | -90.4% | 120,612 | -84.8% | 0.05% | -90.5% |
| Q2 2015 | $5,714,000 | +28.7% | 792,571 | +31.6% | 0.56% | +28.3% |
| Q1 2015 | $4,440,000 | +3569.4% | 602,451 | +2165.6% | 0.44% | +4250.0% |
| Q2 2014 | $121,000 | -92.4% | 26,591 | -91.7% | 0.01% | -86.7% |
| Q4 2013 | $1,600,000 | -63.9% | 319,430 | -55.2% | 0.08% | -62.9% |
| Q3 2013 | $4,432,000 | +30.1% | 712,491 | -5.0% | 0.20% | +41.3% |
| Q2 2013 | $3,407,000 | – | 750,360 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |